XT
EVGN icon

XTX Topco’s Evogene EVGN Stock Holding History

XTX Topco’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.21K Buy
19,404
+6,683
+53% +$4.63K ﹤0.01% 4045
2026
Q1 		$9.79K Sell
12,721
-9,963
-44% -$9.41K ﹤0.01% 3688
2025
Q4 		$25K Buy
+22,684
New +$26.5K ﹤0.01% 3016
2025
Q2 		– Sell
-10,179
Closed -$12.9K – 2584
2025
Q1 		$12.9K Buy
+10,179
New +$15.4K ﹤0.01% 2218
2024
Q3 		– Sell
-1,521
Closed -$9.89K – 2229
2024
Q2 		$9.89K Buy
1,521
+365
+32% +$2.55K ﹤0.01% 1688
2024
Q1 		$8.56K Buy
+1,156
New +$9.64K ﹤0.01% 1683
2021
Q3 		– Sell
-2,117
Closed -$72K – 779
2021
Q2 		$72K Buy
+2,117
New +$82.9K 0.02% 695

Other funds holding EVGN

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $137M AUM
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
SWM
SHP Wealth Management Plymouth, Massachusetts $1.45B AUM

XTX Topco's EVGN Position: Q2 2026 in Review

XTX Topco increased its Evogene (EVGN) stake by 53% in Q2 2026, buying an estimated $4.63K and bringing the position to 19,404 shares worth $8.21K. The position accounts for ﹤0.01% of the portfolio, ranked #4045.

XTX Topco first reported a position in EVGN in Q2 2021 and has held it in 7 quarters since. The position peaked at $72K in Q2 2021. 13 funds tracked by Wall St. Rank hold EVGN as of Q2 2026.

  • XTX Topco held 19,404 shares of Evogene worth $8.21K as of Q2 2026.
  • XTX Topco bought 6,683 Evogene shares in Q2 2026, an estimated $4.63K.
  • Evogene made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #4045 holding.
  • XTX Topco first reported a position in Evogene in Q2 2021 and has held it in 7 quarters since.
  • XTX Topco's Evogene position peaked at $72K in Q2 2021.
  • 13 funds tracked by Wall St. Rank held Evogene as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.